Senior Global Access Evidence Leader - HTA Statistician

F. Hoffmann-La Roche AG; Basel; Vor Ort; CHF 180.000 - 240.000; Vollzeit

Zusammenfassung

Roche is seeking a senior professional to lead EU HTA evidence strategy within the Global Access team. You will shape evidence plans across EU markets, embed robust statistical analyses into development programs, and collaborate with EMA, national payers, and affiliates to optimize access and pricing decisions.

You will drive methodological innovation, align with EU HTA regulations, and translate complex results into compelling narratives for stakeholders.

Qualifikationen

• Master’s or Doctoral-level degree in applied statistics.
• 12+ years of experience in pharma/HTA or related EU regulatory environments.
• Strong background in EU HTA regulations and real‑world evidence.

Aufgaben

• Lead EU HTA evidence strategy and embed evidence plans into clinical development from inception.
• Advance methodological innovation in EU contexts by engaging with HTA bodies and payers.
• Architect region-specific evidence packages for EMA committees and national payers.
• Lead and evaluate complex statistical analyses (NMA, RWE) with rigorous EU HTA compliance.
• Guide affiliates and cross-functional teams on EU submission strategies and EMA pathways.
• Contribute to EU HTA evolution through professional networks and forums.

Kenntnisse

Advanced statistical methods

Cross-functional leadership

Excellent communication in English

Strategic thinking

Data storytelling

Evidence synthesis

Ausbildung

Master’s or Doctoral-level degree in applied statistics

Tools

R

GitLab

SAS

Python

WinBUGS/JAGS

Jobbeschreibung

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary senior professional who thrives in a collaborative environment and is passionate about making a difference. Within GPS, the Global Access (GA) department is dedicated to delivering sustainable, replicable, and scalable global strategies, policies, and solutions. Our mission is to support the Pharma Vision, enabling affiliates to drive patient access locally while improving value for society, healthcare ecosystems, and Roche’s business. We operate in a highly networked and agile model with stable chapters and flexible squads and work teams across the product lifecycle, disease areas, functions, and geographies, with chapters built around the expertise and capabilities needed to co‑create and deliver integrated solutions.

The Opportunity

• Lead EU HTA evidence strategy: Shape Roche’s approach to EU HTA submissions by embedding sophisticated, anticipatory evidence strategies into clinical development from inception, ensuring alignment with EMA regulations, and the new EU HTA regulations. Position us as a benchmark for evidence excellence across European markets.
• Drive methodological innovation in EU contexts: Leverage your established networks within European HTA bodies, payers, and health authorities to advance evidence standards and best practices—influencing how the industry approaches submissions to national HTA organizations and contributing to the evolution of EU HTA frameworks.
• Architect compelling EU submissions: Design innovative, region‑specific evidence packages that anticipate the needs of EMA committees, HTA bodies and national payers. Identify strategic evidence gaps early, pioneer novel data sources and analyses, and translate complex statistical findings into narratives that drive reimbursement and access decisions across EU markets.
• Establish Roche as an EU HTA expert: Leverage your reputation and deep relationships within the European Access/HTA ecosystem to elevate submission quality, engage proactively with key opinion leaders and HTA bodies, and position Roche as a thought leader in EU evidence generation and submission strategy.
• Lead strategic statistical analysis for EU evidence packages: Lead and critically evaluate complex statistical analyses—including network meta‑analyses and real‑world evidence syntheses—ensuring methodological rigor and compliance with EU HTA requirements while translating findings into compelling, region‑appropriate narratives.
• Enable affiliates and cross‑functional teams: Guide European affiliate teams and cross‑functional partners in building robust EU submission strategies, ensuring alignment across EMA development pathways and national HTA submissions, and mentor colleagues on evolving EU regulatory and HTA landscapes.
• Contribute to EU HTA evolution: Maintain influential engagement with European HTA bodies, regulatory agencies, and academic networks—actively participating in professional forums, contributing to methodological debates, and ensuring Roche remains at the forefront of EU evidence standards and innovation.

Who You Are

• Advanced expertise & experience in EU HTA: You hold a Master’s or Doctoral‑level degree in applied statistics and bring 12+ years of deep, hands‑on experience in the pharmaceutical industry, health economics/HTA consultancy, European payer organizations, EMA‑regulated environments, or academic research with progressive strategic influence in European markets.
• Recognized standing in the European HTA community: You are a known voice actively engaged with European HTA networks, national HTA bodies, or equivalent professional networks, holding established relationships with key opinion leaders and contributing to methodological discussions through publications, conference presentations, or advisory roles.
• Deep knowledge of the EU HTA landscape: You demonstrate a thorough understanding of the EU HTA Regulation (2021/2282) and joint clinical assessment procedures, national HTA requirements across major European markets (UK, Germany, France, Italy, Spain, etc.), EMA scientific advice and conditional approval pathways, and real‑world evidence requirements in EU contexts.
• Master‑level statistical expertise & strategic vision: You possess mastery of advanced statistical methods (Generalized Linear Models, Survival Analysis, Network Meta‑Analysis, Bayesian methods, real‑world evidence analyses) using R and contemporary tools (GitLab, SAS, Python, WinBUGS, JAGS), paired with the ability to think strategically about EU market access and nuances across European healthcare systems.
• Collaborative leadership & exceptional communication: You excel at leading cross‑functional teams in matrix environments, engaging with European affiliate teams and external HTA bodies, and possess outstanding written and verbal communication skills in English (and ideally German, French, or other European languages) to translate technical analyses into compelling narratives.

Ready for the next step? We look forward to hearing from you.

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life‑changing healthcare solutions that make a global impact. Let’s build a healthier future, together. Roche is an Equal Opportunity Employer. We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world. That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow. We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world. We are Roche.